Home/Vantis Vascular/Jason Turner
JT

Jason Turner

Chief Executive Officer

Vantis Vascular

Vantis Vascular Pipeline

DrugIndicationPhase
Next-Generation Intravascular Lithotripsy (IVL)Complex Calcified Lesions (Coronary/Peripheral)Development
Peripheral (BTK) SolutionBelow-the-Knee Peripheral Artery DiseaseDevelopment